ALSO READBafna Pharmaceuticals reports standalone net loss of Rs 8.37 crore in the March 2017 quarter Bafna Pharmaceuticals to hold board meeting Bafna Pharmaceuticals to announce Quarterly Result Bafna Pharmaceuticals to announce Quarterly Result Board of Bafna Pharmaceuticals accepts resignation of company secretary
Sales decline 56.99% to Rs 9.10 croreNet Loss of Bafna Pharmaceuticals reported to Rs 7.61 crore in the quarter ended June 2017 as against net loss of Rs 2.90 crore during the previous quarter ended June 2016.
Sales declined 56.99% to Rs 9.10 crore in the quarter ended June 2017 as against Rs 21.16 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales9.1021.16 -57 OPM %-33.853.64 -PBDT-4.98-1.94 -157 PBT-5.91-2.95 -100 NP-7.61-2.90 -162
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)